Tango Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -51.97M-58.24M-108.22M-101.74M-130.30M
Depreciation and Depletion 0.72M0.90M1.61M2.42M2.50M
Share-based Compensation 1.76M7.83M14.23M19.08M28.90M
Gains from Sales and Divestitures 0.79M0.26M0.04M0.26M
Gains from Investment Securities 4.09M9.37M12.92M16.73M19.62M
Non-cash Items 6,635.63M2.12M4.68M7.88M2.16M
Cash from Operations 70.07M-59.53M-109.08M-117.98M-131.50M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.91M1.07M2.42M3.61M-4.62M
Depreciation & Amortization (CF) 0.72M0.90M1.61M2.42M2.50M
Change in Working Capital
Change in Receivables 2.00M-2.00M
Change in Account Payables 1.17M1.23M1.10M-1.71M-1.18M
Change in Accured Expenses 1.20M3.83M7.63M-2.03M1.13M
Change in Taxes 0.01M
Other Working Capital Changes 119.08M-12.04M-16.86M-31.53M-29.97M
Investing Activities
Capital Expenditures 1.11M1.84M7.69M1.53M0.75M
Change in Acquisitions & Divestments 63.22M190.76M242.59M353.53M327.77M
Cash from Investing Activities -145.47M-183.43M26.40M41.43M86.13M
Financing Activities
Other financing activities 3.59M0.01M0.24M
Cash from Financing Activities 80.88M357.32M1.61M82.41M47.66M
Additional items
Change in Cash 5.49M114.36M-81.07M5.85M2.29M
Beginning Cash Balance 25.17M30.66M141.03M63.96M67.24M
Free Cash Flow 68.97M-61.36M-116.77M-119.51M-132.25M
Net Cash Flow 5.49M114.36M-81.07M5.85M2.29M